Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alliancells Institute
Heze, Shandong, China
- Ownership
- Private
- Development stage
- Other
01
Overview
Early clinical studies show safety and potential efficacy for cell therapy products in liver cirrhosis, rheumatoid arthritis, and oncology. Human umbilical cord mesenchymal stem cells (HUMSCs) and cytokine-induced killer (CIK) cells under study in Phase 1/2 trials; results suggest possible protective or anti-inflammatory effects in animal or patient models
- Therapeutic areas
- Women's HealthOncologyGastroenterologyImmunology
- Modalities
- Cell therapyStem cell therapy
- Industry
- Biotech
Beyond the preview
Go deeper on Alliancells Institute.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Alliancells Institute.